InvestorsHub Logo
Followers 130
Posts 14996
Boards Moderated 1
Alias Born 06/04/2018

Re: None

Thursday, 06/27/2019 2:00:23 PM

Thursday, June 27, 2019 2:00:23 PM

Post# of 8457
News: $NVAX Novavax Confirms Accelerated Approval Pathway Available for Licensure of NanoFlu(TM)

Pivotal Phase 3 clinical trial expected to initiate in the fall of 2019 Top-line clinical data expected in the first quarter of 2020 GAITHERSBURG, Md., June 27, 2019 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccine...

Find out more https://marketwirenews.com/news-releases/novavax-confirms-accelerated-approval-pathway-available-for-lic-8423344.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NVAX News